Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Tak 733
2. Tak-733
3. Tak733
1. Tak-733
2. 1035555-63-5
3. Tak733
4. Tak 733
5. Mek Inhibitor Tak-733
6. 5j61hsp0qj
7. Chembl1615025
8. 3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione
9. Unii-5j61hsp0qj
10. (r)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido(2,3-d)pyrimidine-4,7(3h,8h)-dione
11. Mls006011054
12. Gtpl9911
13. Schembl1528606
14. Tak-733 [who-dd]
15. Dtxsid20648089
16. Example 18 [us8470837]
17. Bcp06625
18. Ex-a2164
19. Bdbm50337926
20. Mfcd24386349
21. Nsc761215
22. Nsc800940
23. S2617
24. Zinc43196550
25. Akos027251050
26. Ccg-264969
27. Cs-1283
28. Db12241
29. Nsc-761215
30. Nsc-800940
31. Compound 17 [pmid: 21310613]
32. Ncgc00263187-01
33. 3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione
34. Hy-13449
35. Smr004702846
36. Sw220152-1
37. Us8470837, 18
38. A857992
39. Q27262384
40. (r)-3-(2,3-dihydroxypropyl)-6-fluoro-5-((2-fluoro-4-iodophenyl)amino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione
41. 3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido [2,3-d]pyrimidine-4,7(3h,8h)-dione
42. Izg
43. Pyrido[2,3-d]pyrimidine-4,7(3h,8h)-dione,3-[(2r)-2,3-dihydroxy-propyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methyl-
| Molecular Weight | 504.23 g/mol |
|---|---|
| Molecular Formula | C17H15F2IN4O4 |
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 504.01061 g/mol |
| Monoisotopic Mass | 504.01061 g/mol |
| Topological Polar Surface Area | 106 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 772 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
66
PharmaCompass offers a list of Tak-733 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tak-733 manufacturer or Tak-733 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tak-733 manufacturer or Tak-733 supplier.
PharmaCompass also assists you with knowing the Tak-733 API Price utilized in the formulation of products. Tak-733 API Price is not always fixed or binding as the Tak-733 Price is obtained through a variety of data sources. The Tak-733 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A TAK 733 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TAK 733, including repackagers and relabelers. The FDA regulates TAK 733 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TAK 733 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A TAK 733 supplier is an individual or a company that provides TAK 733 active pharmaceutical ingredient (API) or TAK 733 finished formulations upon request. The TAK 733 suppliers may include TAK 733 API manufacturers, exporters, distributors and traders.
TAK 733 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TAK 733 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TAK 733 GMP manufacturer or TAK 733 GMP API supplier for your needs.
A TAK 733 CoA (Certificate of Analysis) is a formal document that attests to TAK 733's compliance with TAK 733 specifications and serves as a tool for batch-level quality control.
TAK 733 CoA mostly includes findings from lab analyses of a specific batch. For each TAK 733 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TAK 733 may be tested according to a variety of international standards, such as European Pharmacopoeia (TAK 733 EP), TAK 733 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TAK 733 USP).
